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Summary: In a prospective study, 218 cardiothoracic patients, in whom 
‘Abbocath-T’ cannulae had been inserted preoperatively into the internal 
jugular vein, were randomized to receive skin preparation of the insertion site 
with tincture of iodine (108 controls) or tincture of iodine followed by 
application of sterile 2% calcium mupirocin ointment (110 test patients). 
Cannulae were usually removed within 48 h of the operation. Patients 
receiving mupirocin were less likely to develop significant colonization of one 
or more of their cannulae as judged by Maki’s criterion of a yield of > 15 
colony forming units (cfu) from a cannula segment rolled on an agar plate 
(17% of mupirocin treated patients compared with 54% of the controls, 
P < 0.001). Coagulase-negative staphylococci, micrococci, or both, were the 
commonest isolates and were cultured from 70% of the 186 control cannulae 
compared with 24% of 172 cannulae inserted through mupirocin-treated skin 
(P < 0.001). A count of more than 15 cfu was found on the tips of 25% 
control cannulae compared with 5% of the cannulae from mupirocin-treated 
patients, an effect which was independent of in-situ time (P < 0.001). For 
cannulae with colonized tips, the same species was isolated from the skin of 
the insertion site in 67%, from the exterior of the hub in 61% and from the 
lumen in only 15%. There were no side effects attributed to mupirocin or 
superinfection with resistant organisms. We conclude that in cardiothoracic 
patients the application of mupirocin after standard skin preparation with 
tincture of iodine significantly reduces the colonization of central venous 
cannulae by organisms derived from the skin insertion site. 
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Introduction 
Although modern medicine and surgery are often dependent on the use of 
intravascular cannulae, colonization of cannulae, particularly with 
staphylococci derived from the skin of the insertion site, may progress to 
local sepsis and episodes of life-threatening septicaemia (Maki, 1982; Elliot, 
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1988). In a European survey of 10 616 surgical patients, 4.48% of those with 
central venous lines acquired a bacteraemia (Nystrom et al., 1983). In the 
USA up to one-third of all hospital-acquired bacteraemias are derived from 
vascular cannulae (Maki, 1982) and in one UK hospital, infection of central 
venous cannulae was the commonest focus for bacteraemia with 
Staphylococcus aureus (Gransden, Eykyn & Phillips, 1984). 
Appropriate antimicrobial chemoprophylaxis may reduce the risk of 
cannula-related infection (Pezzarossi et al., 1986; Maki & Ringer, 1987) but 
once an infection is established, systemic therapy may be ineffective and the 
cannula has to be removed (Peters & Pulverer, 1984; Young & Sugarman, 
1985; Editorial, 1988). Application of a topical antibiotic to the skin of the 
insertion site has in general not been of benefit (Norden, 1969; Zinner et al., 
1969;) although ointment containing polymyxin, neomycin and bacitracin 
reduced colonization of cannulae in one study by about two-thirds (Maki & 
Band, 1981). 
The recent introduction of mupirocin, a non-systemic antibiotic with 
high in-vitro anti-staphylococcal activity (Casewell & Hill, 1985; White et 
al., 1985) and efficacy in the anterior nares (Casewell & Hill, 1986; Hill, 
Duckworth & Casewell, 1988) and on skin (Casewell & Hill, 1987) 
prompted us to evaluate its efficacy when applied directly to the cannula 
insertion site. 
Materials and methods 
Patients and skin preparation 
Between January and September 1987, 244 patients undergoing elective 
cardiothoracic surgery at King’s College Hospital routinely had two, but 
occasionally one or three, internal jugular cannulae inserted percutaneously 
into different but adjacent puncture sites, immediately after induction of 
anaesthesia. Preoperatively, all patients had one to five baths and skin 
cleansing with ‘Triclosan’ (Hough, Hoseason & Co Ltd). Routine 
perioperative chemoprophylaxis consisted of gentamicin (80 mg) plus 
flucloxacillin (500 mg) or erythromycin (500 mg), both given before 
cannulation and then 8-hourly for 48 h. 
By means of randomization tables, patients were assigned on a weekly 
basis as ‘test’ or ‘control’ for skin preparation of the cannula insertion site; 
the microbiologists processing the specimens were unaware of the patient’s 
allocation. Control patients received only standard skin preparation of the 
cannula site with tincture of iodine (2.5% in 90% methyl alcohol). After the 
tincture had dried the test group received, in addition, a bolus 
(approximately 10 mm squeezed from a 15 g tube) of sterile 2% calcium 
mupirocin in a white soft paraffin base (SmithKline Beecham) applied 
directly to the cannulation skin site. The internal jugular vein was then 
cannulated through the prepared skin area with two or three 16 gauge, 5.5 
inch (12.3 cm) ‘Abbocath-T’ (Abbott Laboratories Ltd) cannulae using a 
no-touch technique, but without sterile drapes, gowns or gloves. Test 
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patients then received a second application of mupirocin to the puncture 
site. A further application of test or control treatments was made whenever 
cannulae were re-dressed. For all patients, the cannulation site, cannula hub 
and giving-set connections were covered and immobilized with ‘Op-site’ 
dressing (Smith and Nephew Ltd). 
A dedicated research infection control nurse assessed cannula sites for 
inflammation or the presence of pus at redressing and at decannulation 
which was usually within 48 h of surgery. Other clinically evaluable data 
that were recorded included the indications for cardiothoracic surgery, 
difficulty of cannula insertion, in-situ time, antibiotic therapy and all 
information pertaining to infection including the results of blood cultures 
and other specimens taken for clinical indications. 
Microbiology 
The skin of the cannulation site was sampled before the application of 
antiseptics with a cotton-wool tipped swab moistened in nutrient broth 
(Oxoid CMl) which was rubbed over an area of approximately 2.5 cm*. At 
decannulation, the exterior of the hub and skin adjacent to the cannula and 
puncture site were sampled with an alginate-tipped swab (Medical Wire Co. 
Ltd) moistened in nutrient broth. Immediately before decannulation, 
residual mupirocin adjacent to the insertion site was removed with sterile 
gauze and an alcohol-impregnated swab. After cannula withdrawal, 5 ml of 
double-strength nutrient broth from a syringe was flushed through the 
lumen into 5 ml of double-strength Robertson’s cooked meat broth (Oxoid 
CM81). The sheath was then cut aseptically from the hub and transported 
to the laboratory in a sterile test tube. 
In the laboratory, approximately 50 mm of the intravenous section of the 
cannula tip and the intracutaneous part of the cannula were rolled back and 
forth five times across separate blood agar plates according to the 
semi-quantitative method of Maki (Maki, Weise & Saraffin, 1977) and then 
placed in cooked meat broths (Oxoid CM81) for enrichment culture. Lumen 
flush broth (0.005 ml) was inoculated on blood agar and the remainder 
incubated for enrichment. Semi-quantitative cultures and those of the skin 
swab and lumen flush were incubated aerobically for 18-24 h. Enrichment 
broths were sub-cultured after 18-24 h on blood agar plates and incubated 
aerobically for 18-24 h and anaerobically for 72 h. All incubations were at 
37°C. Isolates were identified using standard methods (Cowan, 1974), 
(API/Bio Merieux UK Ltd). Cannulae yielding organisms by enrichment 
culture only were defined as contaminated, and those yielding > 15cfu from 
semi-quantitative cultures of the intracutaneous segment or the tip were 
considered to be significantly colonized, in accordance with Maki’s criterion 
(Maki, 1982). Antibiotic sensitivities were determined by a controlled 
disc-diffusion method using 5% lysed horse-blood DST agar (Oxoid CM 
261). Methicillin sensitivity was determined at 30°C. Minimum inhibitory 
concentrations (MI&) of mupirocin were determined as previously 
described (Casewell & Hill, 1985). 
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Statistical analysis 
The significance of differences between test and control groups was 
determined with the x2 or Fisher’s two-sided exact test for categorical data. 
Results 
Of the 244 patients receiving cardiothoracic surgery, 26 were excluded from 
the analysis: four patients in the mupirocin group and two controls died of 
unrelated causes before cannulae were obtained. Ten other patients in each 
group were excluded because no cannulae were obtained for culture. For the 
218 patients studied, the features of the 110 mupirocin patients and the 108 
controls were very similar (Table I). In both groups there was a 
predominance of males aged SC&60 yrs, most of whom underwent coronary 
artery bypass graft operations. A slightly higher proportion of mupirocin 
patients (13% compared with 2% controls) received non-standard 
prophylaxis, mostly because of concern about possible gentamicin- and 
methicillin-resistant Staphylococcus aureus (MRSA) in the hospital for 
about 10 days. No significant difference for the outcome of cannulae for this 
subgroup could be detected when compared with the patients in the 
mupirocin group who had received standard prophylaxis. The majority of 
patients in both treatment groups had two cannulae inserted into the 
internal jugular vein-88% in the mupirocin group and 94% in the control 
group. All patients had at least one cannula cultured and complete data was 
obtained for 358 cannulae. The cannula-related risk factors including ease 
of cannulation, in-situ time, and the presence of other cannulae at 
decannulation, were similar for mupirocin and control groups (Table II). 
Table I. Features of patients in mupirocin and control groups 
Controls Mupirocin 
Number studied 108 110 
Median age (range) in yrs 55 (14-75) 
Male (%) 
58 (3tS87) 
81 82 
Operation (“,) 
Coronary artery by-pass graft alone 79 80 
Valve replacement 15 16 
Both 2.8 1.8 
Congenital anomaly correction 9.2 9.8 
Aneurysm 0.9 2.7 
Prophylaxis (%) 
Gentamicin + flucloxacillin/ 
erythromycin 98 87 
Other 2 13 
Number of cannulae (%) 
One 
Two 9: 8: 
Three 6 9 
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Cannulae cultured Mupirocin Controls 
Total number 
Cannulation (%) 
Easy 
Difficult 
Unknown 
In situ time (%) 
<24h 
2448 h 
48-120 h 
At decannulation, % from patients: 
with one other cannula in-situ 
with two other cannulae in-situ 
receiving systemic antibiotics 
172 186 
73 79 
18 18 
9 3 
60 57 
29 38 
11 5 
64 87 
0 1 
100 100 
Although cannula-related bacteraemia was not detected in any of the 
mupirocin or control patients, and there was no significant difference in the 
incidence of erythema or pus at the insertion site (Table III), the 
application of mupirocin was consistently associated with a reduction in the 
proportion of patients with contamination or colonization of cannulae. As 
judged by positive enrichment or semiquantitative cultures, there was more 
than a two-fold reduction in the proportion of patients with one or more 
contaminated or colonized cannulae: 36% of the mupirocin-treated patients 
compared with 77% of the controls (Table III; P < 0.001). The reduction 
in the proportion of patients with significant colonization of any cannula, as 
judged by the culture of > 15 cfu from any cannula segment, was even 
greater: 18 (17%) of the 110 mupirocin patients compared with 58 (54%) of 
the 108 controls (P < 0.001). 
Figure 1 shows that the proportion of cannulae with colonization 
(> 15 cfu) of the intracutaneous segment or cannula tip, or with > 15 cfu 
from 0.005 ml of the cannula lumen flush, increased with in-situ time, and 
that patients were most likely to have positive intracutaneous segments. 
Table III. Patient outcome in mupirocin and control groups 
No. of patients (%) 
Patients 
Mupirocin 
n=llO 
Controls 
n=108 P-value 
Any cannula 
Contaminated or colonized 
Colonized ( > 15 cfu) 
Erythema but no pus 
Pus 
Cannula-related bacteraemia 
39 (36) 83 (77) < 0.001 
18 (17) 58 (54) < 0.001 
24 (22) 22 (20) NS* 
l( 1) 3 (2.7) NS 
0 0 
*NS = not significant. 
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Figure 1. Effect of mupirocin on proportion of patients with one or more colonized cannulae 
related to in-situ time. Colonization defined as > 15 cfu from intracutaneous segment or tip, 
or from 0.005 ml of lumen flush. 
Mupirocin significantly reduced the proportion of patients with 
culture-positive intracutaneous segments and cannula tips and this was 
significant (P < 0.001) regardless of whether the patient had the cannula 
in-situ for < 24 h, 24-48 h or 48-120 h. Only six patients, three in each 
group, had cannulae with positive luminal cultures. 
All species isolated by semi-quantitative or enrichment techniques from 
any part of the 358 cannulae from the control and mupirocin groups are 
shown in Table IV. Overall, species considered to be skin flora, i.e. 
coagulase-negative staphylococci, micrococci, corynebacteria and 
Acinetobacter species accounted for more than 90% of all isolates from both 
mupirocin and control cannulae. More than one species was isolated from 
different parts of the same cannula for 24 control and 10 mupirocin 
cannulae. Cultures, including enrichment, of the cannula tip, 
intracutaneous segment, and lumen all yielded no growth significantly more 
often for cannulae that had been inserted through mupirocin treated skin: 
64% of 172 cannulae from mupirocin patients compared with 23% of the 
186 from the controls (P < 0.001). If only cannulae from patients who had 
all their cannulae cultured were considered, the level of significant 
difference was unaltered as 53% of 119 cannulae from mupirocin patients 
yielded no growth compared to 12% of 133 control cannulae (P < 0.001). 
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Organisms 
- 
No growth 
Coagulase-negative staphylococci 
Micrococci 
Corynebacteria 
Ent. aglomerans 
A. calcoaceticus 
Staph. aureus 
Other enterobacteriaceae 
Ps. testosteroni 
Moraxella sp. 
Strep. lactis 
Controls Mupirocin 
(n= 186) (n= 172) 
23 
62 
2 
2 
0.5 
0.5 
0.5 
% of Cannulae 
64* 
19 
5 
:, 
1 
2 
0 
i 
0 
Organisms isolated by enrichment or semi-quantitative techniques from 
the cannula tips were usually sensitive to the prophylactic systemic 
antibiotics although 4% of the tip isolates were resistant to both gentamicin 
and flucloxacillin. All Gram-negative organisms were sensitive to 
gentamicin. Mupirocin-resistant coagulase-negative staphylococci, with 
MICs of 8 to > 128 mgl-‘, were isolated from lo/84 (12%) of colonized 
cannula tips in the control group and from 2/20 (10%) of those from the 
mupirocin-treated patients; for these two mupirocin-treated patients the 
resistant isolates were also detected in skin swabs taken before the 
application of mupirocin. MICs for mupirocin-sensitive isolates of 
coagulase-negative staphylococci and corynebacteria ranged from 
0.015-0.5 mg 1-l of mupirocin. 
Table V shows that using Maki’s criteria for significant colonization, 
> 15 cfu were isolated from only 8 (5%) of the tips of 172 cannulae inserted 
through mupirocin-treated skin insertion sites, compared with 46 (25%) of 
the 186 controls (P < O*OOl). The organisms isolated from significantly 
colonized tips corresponded most often with those from the exterior of the 
hub, or the skin of the insertion site. Of the 46 colonized cannula tips in the 
control group, indistinguishable isolates were found from the skin for 67%, 
from the exterior of the hub for 61%) and from the lumen for only 15 % of 
cannulae. For the eight colonized cannulae from the mupirocin group, the 
tip isolate was identified on the skin, from the hub exterior, and from the 
lumen once only in three different cannulae (P < 0.001). Using Maki’s 
criteria, significant colonization of cannula tips was more common with 
longer in-situ times but mupirocin significantly reduced the colonization for 
all in-situ times (Table V). None of the 19 cannulae inserted through 
mupirocin-treated skin that were in-situ for 48-120 h were colonized 
compared with six of the 10 controls. 
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Table V. Significant colonization of cannula tips as judged by Maki’s criteria according to in-situ time 
In-situ 
time (h) 
Number colonized (%) 
Controls . Mupirocin 
n=186 n=172 
P-value 
124 105 (15) 103 ( 3) < 0.001 
24-48 71 (34) 50 (10) -=c 0.025 
> 48-l 20 10 (60) 19( 0) < 0.001 
All cannulae 186 (25) 172 ( 5) < 0.001 
Discussion 
Our results show clearly that the application of mupirocin to the skin of the 
cannula insertion site reduces the subsequent contamination and significant 
colonization of cannulae. Our patients and their cannulae were well 
matched in the test and control groups. All patients underwent 
cardiothoracic surgery, and had ‘Abbocath-T’ cannulae inserted 
preoperatively under standard conditions by the same group of 
anaesthetists. Previous studies have usually reported results on more 
heterogeneous groups of patients and cannula types (Norden, 1969; Zinner 
et al., 1969; Maki & Band, 1981). 
In this study, we concentrated on the earliest events in patients with 
central venous cannulae in the light of Maki’s work which showed that 
contamination and established colonization of the cannula (> 15 cfu) is 
widely accepted as a predictor of subsequent cannula-related sepsis and 
bacteraemia (Maki et al., 1977; Maki, 1982; Moyer, Edwards & Farley, 
1983; Elliot, 1988). As judged by enrichment culture mupirocin increased 
to 64% the proportion of patients who yielded sterile cannulae from 23 % in 
the controls. More importantly, by the semi-quantitative technique only 
17% of patients receiving mupirocin had any cannulae that yielded 
> 15 cfu, compared with 54% of the controls. The cannula tip is probably 
the most important site for colonization with > 15 cfu and consideration of 
all 358 cannulae showed that there was a five-fold reduction of tip 
colonization to 5% in the mupirocin group; this effect was found regardless 
of in-situ times up to 120 h. We have not been able to find reductions of this 
magnitude in the published literature although the application of an 
ointment containing neomycin, bacitracin and polymyxin resulted in the 
colonization rate of mainly peripheral lines being reduced from 6.5% to 
2.2% compared to 3.6% for povidone-iodine ointment (Maki & Band, 
1981). More recently Maki, by using a biodegradable collagen subcutaneous 
cannula cuff that released silver ions, achieved a reduction in colonization 
rate of central venous lines from 28.9% to 9.1% (Maki et al., 1988). 
The organisms isolated from colonized cannula tips corresponded most 
often to isolates from the insertion-site skin or the intracutaneous segment 
Mupirocin and intravenous cannulae 319 
rather than to the infrequent isolates from the cannula lumen. For our 
cardiothoracic patients at least, this, taken with the efficacy of topical 
mupirocin, supports the view that it is the skin of the insertion site, rather 
than the lumen, that serves as the major source of organisms for 
colonization of the cannula tip (Bjornson et al., 1982; Snydman et al., 1982; 
Jakobsen, Grabe & Damm, 1986; Cercenado et al., 1988; Conly, Grieves & 
Peters, 1988; Maki, 1988). Indeed, Cooper & Hopkins (1985) have shown 
by Gram staining that organisms are found on the surface of the cannula 
rather than in the lumen and that these organisms may reach the tip by 
capillary action (Cooper, Schiller & Hopkins, 1988). In-line filtration, 
which could potentially prevent contaminants being introduced into the 
lumen via a hub, does not significantly reduce sepsis (Murphy & Lipman, 
1987). Nevertheless, the junction between the cannula and the ‘giving set’ 
may assume importance (Deital et al., 1983; Linares et al., 1985) 
particularly for long-term lines which have frequent ‘make and break’ 
connections, for example during parenteral nutrition (Sitges-Serra et al., 
1983 & 1984) or haemodialysis (Cheesbrough, Finch & Burden, 1986; 
Jakobsen et al., 1989). The presence of another cannula has been suggested 
as a risk factor for the development of cannula-related sepsis but its 
significance has not been proved (Petersen et al., 1985). 
In addition to the reduction in the mupirocin group of cannula 
contamination and colonization with coagulase-negative staphylococci and 
micrococci, there were fewer cannulae yielding species of corynebacteria, 
Acinetobacter and Enterobacteriaceae. Although the low numbers do not 
reach statistical significance we wonder whether this reflects a useful effect 
of 2% (20 000 mg 1-l) mupirocin against these species that are usually 
considered ‘resistant’ (White et al., 1985). A trial of mupirocin, applied to 
the insertion site of cannulae left in-situ for more than 48 h, would indicate 
whether, with more prolonged use, mupirocin-resistant strains of 
staphylococci emerge (Baird & Coia, 1987; Rahman, Noble & Cookson, 
1987; Smith & Kennedy, 1988) and whether super-infection with 
Gram-negative bacilli, yeasts or other fungi ultimately occurs. None of 
these theoretical complications were found in the first few days of 
cannulation in our cardiothoracic surgical patients and there were no 
adverse local effects attributed to mupirocin. 
We conclude that 2% calcium mupirocin applied to the insertion site, in 
addition to standard skin disinfection with tincture of iodine, significantly 
reduces the risk of the earliest events in the pathogenesis of cannula-related 
sepsis in these patients. 
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